Delcath Systems Stock

Delcath Systems EBITDA per Employee

The EBITDA per Employee of Delcath Systems (DCTH) as of Aug 8, 2026 is 15,348.84 USD. In the previous year, EBITDA per Employee was -288,604.65 USD — a change of -105.32% (higher).

EBITDA per Employee

15,348.84USD

YoY

-105.32%

Last updated:

EBITDA per Employee of Delcath Systems is 2026 15,348.84 USD. EBITDA per Employee of Delcath Systems was 2025 -288,604.65 USD. It decreases by -105.32% higher compared to the previous year.
Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

EBITDA per Employee of Delcath Systems is 15,348.84 USD in 2026.

EBITDA per Employee of Delcath Systems changed from -288,604.65 USD to 15,348.84 USD, representing a -105.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Delcath Systems historically and in real time.

Access this data via the Eulerpool API

Workforce — Delcath Systems

All Key Metrics — Delcath Systems